Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Use of idarucizumab for dabigatran reversal in patients with non-valvular atrial fibrillation undergoing emergency surgical repair of strangulated femoral hernia
Non-vitamin-K oral anticoagulants (NOACs) are approved for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) and dabigatran exetilate, a direct thrombin inhibitor, was the first one to...